Soliris (eculizumab)

pCPA File Number: 21306
Negotiation Status:
Concluded without agreement
Indication(s):
Myasthenia Gravis
Sponsor/Manufacturer:
Alexion Pharma Canada Corp.
CDA-AMC Project Number:
SR0605-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: